DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20211445

Prevalence of neuropathy in type 2 diabetic patients at sub-district hospital Akhnoor

Chandan Sharma, Ashima Badyal

Abstract


Background: Type 2 diabetes mellitus (T2DM) is a progressive disease and hampers the quality of life of the patients due to micro and macro-vascular complications associated with it, like: neuropathy. Peripheral neuropathy leads to numbness, loss of sensation, and sometimes pain in the feet, legs, or hands.

Methods: A cross sectional study was conducted among 200 randomly selected T2DM patients of either gender presenting to the medicine outpatient department (OPD) of sub district hospital Akhnoor from August 2020 to February 2021.

Results: Almost half of the participants having duration of DM for more than 10 years and a mean age of 56.8±12.2 years. Based on the Michigan neuropathy screening instrument (MNSI) assessment, 41% of study participants had a score of ≥6 in the history questionnaire. The most frequently reported symptoms among patients were numbness and pain while walking, which was present in 80.5% and 70.5% of study participants, respectively. Around 32-40.5% of T2DM patients were found to suffer from peripheral neuropathy in our study. A significantly higher prevalence of diabetic peripheral neuropathy (DPN) was found among males (43.7%) than females (37.1%).

Conclusions: Early detection of DM and appropriate intervention and effective control is important for effective management among patients, especially with higher body mass index (BMI), obesity or with advancing age.

 


Keywords


Diabetes, Peripheral neuropathy, Quality of life

Full Text:

PDF

References


Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311-21.

Mohan V, Shah S, Saboo B. Current glucemic status and diabetes related complicationamong type 2 diabetes patients in india:data from the Achieve study. J Assoc Physicians India. 2013;61:12-5.

Jabish AS. Is diabetes becoming the biggest epidemic of the twenty-first century? Int J Health Sci. 2007:1(2):5-8.

Bansal V, Kalita J, Misra UK. Diabetic Neuropathy. Post grad Med J. 2006;82(964):95-100.

Perrin BM, Allen P, Gardner MJ, Chappell A, Phillips B, Massey C, et al. The foot-health of people with diabetes in regional and rural Australia: baseline results from an observational cohort study. J Foot Ankle Res. 2019;12:56.

Kaewput W, Thongprayoon C, Rangsin R, Jindarat S, Narindrarangkura P, Bathini T, et al. The Association between Serum Uric Acid and Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus: A Multicenter Nationwide CrossSectional Study. Korean J Fam Med. 2020;41(3):189-94.

Sun J, Wang Y, Zhang X, Zhu S, He H. Prevalence of peripheral neuropathy in patients with diabetes: A systematic review and meta-analysis. Prim Care Diabet. 2020;14(5):435-44.

Sendi RA, Mahrus AM, Saeed RM, Mohammed MA, Al-Dubai SAR. Diabetic peripheral neuropathy among Saudi diabetic patients: A multicenter cross-sectional study at primary health care setting. J Family Med Prim Care. 2020;9(1):197-201.

Braffett BH, Gubitosi-Klug RA, Albers JW, Feldman EL, Martin CL, White NH, et al. Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes. 2020;69(5):1000-10.

Shiferaw WS, Akalu TY, Work Y, Aynalem YA. Prevalence of diabetic peripheral neuropathy in Africa: a systematic review and meta-analysis. BMC Endocr Disord. 2020;20(1):49.

Yang Q, Zhang Y, Zeng Q, Yang C, Shi J, Zhang C, et al. Correlation Between Diabetic Peripheral Neuropathy and Sarcopenia in Patients with Type 2 Diabetes Mellitus and Diabetic Foot Disease: A Cross-Sectional Study. Diabetes Metab Syndr Obes. 2020;13:377-86.

Qin L, Niu JY, Zhou JY, Zhang QJ, Zhou F, Zhang N, et al. Prevalence and risk factors of diabetic peripheral neuropathy in Chinese communities. Zhonghua Liu Xing Bing Xue Za Zhi. 2019;40(12):1578-84.

Van der Velde JHPM, Koster A, Strotmeyer ES, Mess WH, Hilkman D, Reulen JPH, et al. Cardiometabolic risk factors as determinants of peripheral nerve function: the Maastricht Study. Diabetologia. 2020;63(8):1648-58.

Huang L, Zhang Y, Wang Y, Shen X, Yan S. Diabetic Peripheral Neuropathy Is Associated With Higher Systolic Blood Pressure in Adults With Type 2 Diabetes with and without hypertension in the Chinese Han population. Can J Diabetes. 2020;44(7):615-23.

Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabet Care. 2017;40(1):136-54.

Barrett EJ, Liu Z, Khamaisi M, King GL, Klein R, Klein BEK, et al. Diabetic Microvascular Disease: An Endocrine Society Scientific Statement. J Clin Endocrinol Metab. 2017;102(12):4343-410.